> "I think it is clear that a lot of studies are conducted with more information than is actually needed; therefore, stripped down models of studies have increasingly greater potential for use in the future," says Genzyme VP Paul Beninger. Report
> ARCA and the FDA have agreed on a protocol that calls for two interim data analyses in a trial for bucindolol, a beta-blocker and vasodilator candidate. If results of either analysis meet spec, they could serve as the clinical effectiveness basis for FDA approval. Announcement
> The OmniComm TrialMaster EDC solution has been at work since 2005 in support of the recently approved Alair Bronchial Thermoplasty System for asthma treatment. Release
> Oracle Argus Safety has triumphed in CRO Quanticate's selection of a database for pharmacovigilance. Article
> Version 8.8 of the Velos eResearch EDC system debuted at the company's annual meeting last week, boasting bio specimen management and enhanced financial management capabilities. Release